HBV Vaccines
HBV-Specific Immune Response Seen in Trial
Published in Vaccine Weekly, April 1st, 1996
Hepatitis B (HBV), a disease prevalent in approximately 350 million people worldwide, causes two million deaths annually. The only approved treatment in the U.S. is alpha interferon, which cures only a small percentage of patients and is often accompanied by undesirable side effects. Poor tolerance due to side effects associated with alpha interferon is believed to derive from stimulation of a general immune response that is not disease-specific.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1996-04-01)
More Articles from Vaccine Weekly
- Conference Coverage (CHI Vaccines)
Microencapsulation Enhances Rotavirus Immunogenicity - Conference Coverage (CHI Vaccines)
Phase II Clinical Trials for Arthritis, Psoriasis Vaccines - Conference Coverage (CHI Vaccines)
Plant-Produced Vaccine Antigens: Safe, Cheap, and Stable - Conference Coverage (CHI Vaccines)
Virus-Like Particle Vaccines for VZV, HIV, Malaria, Hepatitis, More - Conference Coverage (IBC Hepatitis)
DNA Vaccine for HBV Would Offer Many Advantages - AIDS Therapies (Remune)
First Patients Treated in Nationwide Trial of HIV Therapy - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
